CN112979928A - Preparation method of lignin grafted polymer microspheres - Google Patents
Preparation method of lignin grafted polymer microspheres Download PDFInfo
- Publication number
- CN112979928A CN112979928A CN201911311181.9A CN201911311181A CN112979928A CN 112979928 A CN112979928 A CN 112979928A CN 201911311181 A CN201911311181 A CN 201911311181A CN 112979928 A CN112979928 A CN 112979928A
- Authority
- CN
- China
- Prior art keywords
- lignin
- alkylated
- polylactic acid
- microspheres
- grafted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920005610 lignin Polymers 0.000 title claims abstract description 142
- 239000004005 microsphere Substances 0.000 title claims abstract description 63
- 229920000578 graft copolymer Polymers 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 229920000747 poly(lactic acid) Polymers 0.000 claims abstract description 28
- 239000004626 polylactic acid Substances 0.000 claims abstract description 28
- 229920001610 polycaprolactone Polymers 0.000 claims abstract description 18
- 239000004632 polycaprolactone Substances 0.000 claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 12
- 238000005804 alkylation reaction Methods 0.000 claims abstract description 9
- 239000003960 organic solvent Substances 0.000 claims abstract description 8
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 109
- 239000000243 solution Substances 0.000 claims description 53
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 46
- 238000006243 chemical reaction Methods 0.000 claims description 29
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 26
- 239000000178 monomer Substances 0.000 claims description 20
- 239000002904 solvent Substances 0.000 claims description 20
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 16
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- 239000000839 emulsion Substances 0.000 claims description 15
- 239000008367 deionised water Substances 0.000 claims description 13
- 229910021641 deionized water Inorganic materials 0.000 claims description 13
- 229920005604 random copolymer Polymers 0.000 claims description 13
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 11
- 230000004224 protection Effects 0.000 claims description 11
- 239000003995 emulsifying agent Substances 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical group [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 claims description 9
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 claims description 9
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 9
- 235000012538 ammonium bicarbonate Nutrition 0.000 claims description 9
- 239000001099 ammonium carbonate Substances 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 8
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 7
- 239000003513 alkali Chemical class 0.000 claims description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 7
- 238000006116 polymerization reaction Methods 0.000 claims description 7
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 7
- 238000010992 reflux Methods 0.000 claims description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 6
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000003054 catalyst Substances 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 5
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 5
- 239000012498 ultrapure water Substances 0.000 claims description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 claims description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000002798 polar solvent Substances 0.000 claims description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 claims description 4
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 claims description 3
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 claims description 3
- 239000007810 chemical reaction solvent Chemical class 0.000 claims description 3
- 239000011261 inert gas Substances 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000003208 petroleum Substances 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- KSBAEPSJVUENNK-UHFFFAOYSA-L tin(ii) 2-ethylhexanoate Chemical group [Sn+2].CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O KSBAEPSJVUENNK-UHFFFAOYSA-L 0.000 claims description 2
- JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 238000007334 copolymerization reaction Methods 0.000 claims 2
- 238000010559 graft polymerization reaction Methods 0.000 claims 2
- VSKXVGWORBZZDY-UHFFFAOYSA-N 2-hydroxypropanoic acid;oxepan-2-one Chemical compound CC(O)C(O)=O.O=C1CCCCCO1 VSKXVGWORBZZDY-UHFFFAOYSA-N 0.000 claims 1
- 229920001577 copolymer Polymers 0.000 claims 1
- 239000002407 tissue scaffold Substances 0.000 abstract description 2
- 230000003064 anti-oxidating effect Effects 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 230000000704 physical effect Effects 0.000 abstract 1
- 230000009257 reactivity Effects 0.000 abstract 1
- 238000001035 drying Methods 0.000 description 25
- 239000000047 product Substances 0.000 description 25
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 22
- PBLNBZIONSLZBU-UHFFFAOYSA-N 1-bromododecane Chemical compound CCCCCCCCCCCCBr PBLNBZIONSLZBU-UHFFFAOYSA-N 0.000 description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- 239000002244 precipitate Substances 0.000 description 12
- 229910052786 argon Inorganic materials 0.000 description 11
- 239000011148 porous material Substances 0.000 description 11
- 238000005086 pumping Methods 0.000 description 11
- 238000005406 washing Methods 0.000 description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000001291 vacuum drying Methods 0.000 description 9
- 238000007710 freezing Methods 0.000 description 8
- 230000008014 freezing Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- 238000001816 cooling Methods 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 239000011521 glass Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 5
- 150000001350 alkyl halides Chemical class 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 229920002488 Hemicellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- YCOZIPAWZNQLMR-UHFFFAOYSA-N heptane - octane Natural products CCCCCCCCCCCCCCC YCOZIPAWZNQLMR-UHFFFAOYSA-N 0.000 description 3
- 238000003760 magnetic stirring Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- 230000001376 precipitating effect Effects 0.000 description 3
- 238000010025 steaming Methods 0.000 description 3
- 238000000967 suction filtration Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000012300 argon atmosphere Substances 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- BKIMMITUMNQMOS-UHFFFAOYSA-N nonane Chemical compound CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 2
- 230000005311 nuclear magnetism Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000001878 scanning electron micrograph Methods 0.000 description 2
- BGHCVCJVXZWKCC-UHFFFAOYSA-N tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 description 2
- IIYFAKIEWZDVMP-UHFFFAOYSA-N tridecane Chemical compound CCCCCCCCCCCCC IIYFAKIEWZDVMP-UHFFFAOYSA-N 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 1
- MYMSJFSOOQERIO-UHFFFAOYSA-N 1-bromodecane Chemical compound CCCCCCCCCCBr MYMSJFSOOQERIO-UHFFFAOYSA-N 0.000 description 1
- LSXKDWGTSHCFPP-UHFFFAOYSA-N 1-bromoheptane Chemical compound CCCCCCCBr LSXKDWGTSHCFPP-UHFFFAOYSA-N 0.000 description 1
- MNDIARAMWBIKFW-UHFFFAOYSA-N 1-bromohexane Chemical compound CCCCCCBr MNDIARAMWBIKFW-UHFFFAOYSA-N 0.000 description 1
- AYMUQTNXKPEMLM-UHFFFAOYSA-N 1-bromononane Chemical compound CCCCCCCCCBr AYMUQTNXKPEMLM-UHFFFAOYSA-N 0.000 description 1
- VMKOFRJSULQZRM-UHFFFAOYSA-N 1-bromooctane Chemical compound CCCCCCCCBr VMKOFRJSULQZRM-UHFFFAOYSA-N 0.000 description 1
- JKOTZBXSNOGCIF-UHFFFAOYSA-N 1-bromopentadecane Chemical compound CCCCCCCCCCCCCCCBr JKOTZBXSNOGCIF-UHFFFAOYSA-N 0.000 description 1
- YZWKKMVJZFACSU-UHFFFAOYSA-N 1-bromopentane Chemical compound CCCCCBr YZWKKMVJZFACSU-UHFFFAOYSA-N 0.000 description 1
- KOFZTCSTGIWCQG-UHFFFAOYSA-N 1-bromotetradecane Chemical compound CCCCCCCCCCCCCCBr KOFZTCSTGIWCQG-UHFFFAOYSA-N 0.000 description 1
- BFDNZQUBFCYTIC-UHFFFAOYSA-N 1-bromotridecane Chemical compound CCCCCCCCCCCCCBr BFDNZQUBFCYTIC-UHFFFAOYSA-N 0.000 description 1
- IKPSIIAXIDAQLG-UHFFFAOYSA-N 1-bromoundecane Chemical compound CCCCCCCCCCCBr IKPSIIAXIDAQLG-UHFFFAOYSA-N 0.000 description 1
- SQCZQTSHSZLZIQ-UHFFFAOYSA-N 1-chloropentane Chemical compound CCCCCCl SQCZQTSHSZLZIQ-UHFFFAOYSA-N 0.000 description 1
- OEPRBXUJOQLYID-UHFFFAOYSA-N 1-fluoropentane Chemical compound CCCCCF OEPRBXUJOQLYID-UHFFFAOYSA-N 0.000 description 1
- GCDPERPXPREHJF-UHFFFAOYSA-N 1-iodododecane Chemical compound CCCCCCCCCCCCI GCDPERPXPREHJF-UHFFFAOYSA-N 0.000 description 1
- BLXSFCHWMBESKV-UHFFFAOYSA-N 1-iodopentane Chemical compound CCCCCI BLXSFCHWMBESKV-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 230000007849 functional defect Effects 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229940094933 n-dodecane Drugs 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 229910052756 noble gas Inorganic materials 0.000 description 1
- 150000002835 noble gases Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000004537 pulping Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003356 suture material Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
- C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
- C08G63/08—Lactones or lactides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
- C08H6/00—Macromolecular compounds derived from lignin, e.g. tannins, humic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/26—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a solid phase from a macromolecular composition or article, e.g. leaching out
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2201/00—Foams characterised by the foaming process
- C08J2201/04—Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
- C08J2201/044—Elimination of an inorganic solid phase
- C08J2201/0444—Salts
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Polymers & Plastics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Transplantation (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
本发明提供了一种木质素接枝聚合物微球的制备方法。本发明采用烷基化反应对木质素进行改性，增加其在有机溶剂中的溶解性，从而提高其反应活性，再接枝聚乳酸和/或聚己内酯，制备木质素接枝聚合物微球，提供改变PLA物理性能的手段，降低了成本，也具有抗氧化性等优点。本发明的烷基化木质素接枝聚合物微球，可满足支架材料对于微球应具备的小粒径、高均一性、可降解性和组织相容性的要求，提高多孔支架的安全有效性，降低生产成本，具有抗氧化活性，有望广泛应用于组织支架材料，具有良好的临床应用前景。
The invention provides a preparation method of lignin-grafted polymer microspheres. In the present invention, the alkylation reaction is used to modify the lignin to increase its solubility in an organic solvent, thereby improving its reactivity, and then graft polylactic acid and/or polycaprolactone to prepare a lignin graft polymer Microspheres, which provide a means to change the physical properties of PLA, reduce costs, and also have the advantages of anti-oxidation. The alkylated lignin-grafted polymer microspheres of the invention can meet the requirements of small particle size, high homogeneity, degradability and histocompatibility that the scaffold material should have for the microspheres, and improve the safety and effectiveness of the porous scaffold It can be widely used as a tissue scaffold material, and has a good clinical application prospect.
Description
Technical Field
The invention belongs to the fields of high molecular materials and biomedical engineering, and particularly relates to a preparation method of lignin grafted polymer microspheres.
Background
Tissue engineering is the process of repairing and reconstructing tissue with functional defect to constitute bioactive tissue and organ. The essence is that cell culture technology is utilized to culture cells in vitro or transfer a scaffold tissue structure into a body, and a structure and a tissue organ with corresponding functions are built in the body. The key to the rational utilization of tissue engineering is to find a suitable scaffold material to allow cells to grow and proliferate in the scaffold material well to finally reach a tissue with biological activity, which can exert the repair function (Gaojia. the application of chitosan in the scaffold material of tissue engineering advances [ J ] China cosmetology, 2018(3): 155-.
Tissue engineering porous scaffolds are often required to have a high specific surface area and good inter-pore connectivity, thereby facilitating transport of nutrients and adhesion and growth of cells. Compared with the traditional porous support, the microsphere accumulation type porous support can endow the support with higher specific surface area due to the spherical structure of the accumulation units. Meanwhile, different curvature characteristics of the microsphere surface can generate different influences on behaviors of adhesion, proliferation, migration and the like of cells, and the growth and differentiation of the cells to specific tissues or organs can be induced. The porous structure formed by stacking the microspheres has good connectivity, and is beneficial to the transfer and transportation of nutrient substances (Chinese patent publication CN 102641521A). Microspheres are defined as spherical microparticles, ranging in size from 1 to 1,000 microns, and spheres in size exceeding 1,000 μm are still commonly referred to as microspheres. These microspheres have a wide range of applications, for example in the medical field, in the purification of carrier materials in biochemical science, and as flow indicators.
In recent years, with the rapid development of regenerative medicine and tissue engineering, new tissue engineering scaffolds have become a research hotspot. The tissue engineering material is mainly divided into 3 types (including: Shuhua, Van Yangjiang, Caichia, Liuxia, Dongxiang, Sunpeng.) of natural materials (gelatin, alginate, hyaluronic acid and the like), synthetic materials (polycaprolactone, polylactic acid, polyglycolic acid and the like) and bioactive ceramic materials (hydroxyapatite and the like) (including: Shuhua, Van Changjiang river, Caichuan, Liuxia, Dongxiang, Sunpeng. preparation of covalent cross-linked gelatin microsphere scaffold and osteoblast compatibility research [ J ]. accurate medical journal, 2019,34(3): 268-272.). Polylactic acid (PLA) and Polycaprolactone (PCL) are renewable natural polymers with good biodegradability and biocompatibility, and biomaterials (suture materials or tissue Engineering scaffolds) designed from the natural polymers are widely applied to biomedicine (Kai D, Ren W, Tian L, et al. Engineering poly (lactides) -lignin nanofibers with antibiotic activity for biological application [ J ]. ACS curable Chemistry & Engineering,2016: acussing.6 b 00478.).
The industrial alkaline lignin is a main byproduct of the pulping and papermaking industry and is abundant in reserves. The natural lignin has good antibacterial activity, oxidation resistance and ultraviolet protection performance, and still has wide application prospect when being used as a framework of a drug delivery system. However, the compatibility of the unmodified lignin is poor, and the mechanical property of the composite material is often adversely affected.
Disclosure of Invention
In order to solve the problems in the prior art, the invention provides a lignin graft polymer, wherein the lignin graft polymer is alkylated lignin graft polylactic acid or alkylated lignin graft polycaprolactone or alkylated lignin graft polylactic acid-caprolactone random copolymer.
According to an embodiment of the present invention, the lignin graft polymer comprises a structure as shown in formula (I):
wherein R is1Is selected from C5-15Alkyl, may be C10-12Alkyl, such as dodecyl; r2Selected from polylactic acid chain segment or polycaprolactone or polylactic acid-caprolactone random copolymer.
The invention provides a preparation method of a lignin graft polymer, which comprises the following steps:
(1) alkylation reaction: mixing halogenated alkane, alkali, an organic solvent and lignin, stirring, refluxing, reacting, centrifuging, removing supernatant to obtain a solid, washing with a polar solvent, and drying to obtain alkylated lignin;
(2) polymerization reaction: and (2) removing water from the alkylated lignin obtained in the step (1) by using anhydrous toluene, adding a catalyst and a grafting monomer under the protection of inert gas, and initiating monomer polymerization to obtain a lignin graft polymer.
According to an embodiment of the invention, in step (1) the haloalkane is selected from halo C5-15Alkane, which may be halogenated C10-12Alkanes, preferably bromo-C10-12An alkane, for example, is monobromododecane.
According to an embodiment of the present invention, the lignin of step (1) is prepared from alkali lignin, which comprises dissolving alkali lignin in water, adjusting the pH to a strong alkalinity, and removing insoluble impurities; adjusting the pH value to be strong acid, and centrifuging to obtain purified lignin;
according to an embodiment of the present invention, the reaction solvent in step (1) is a mixed solution of water and an organic solvent; the organic solvent is selected from one or more of methanol, ethanol, n-propanol, isopropanol, n-butanol, tert-butanol, pentanol and hexanol, and is preferably isopropanol; the water is preferably ultrapure water; the volume ratio of water to organic solvent is 1:1 to 5:1, preferably 4: 1.
According to an embodiment of the present invention, the alkylation reaction in step (1) is stirred under reflux for more than 20 hours, preferably more than 60 hours. When the reaction time reaches 60 hours, the alkylated lignin generated in the reaction process is separated out, the viscosity of the reaction system is increased, even solid-liquid separation is carried out, and the reaction end point is reached.
According to an embodiment of the present invention, the polar solvent of step (1) is one or more of n-pentane, n-hexane, n-heptane, cyclohexane or petroleum ether, preferably n-hexane.
According to an embodiment of the invention, in step (1), the mass ratio of haloalkane to lignin is (0.8-14):1, preferably (1-5):1, e.g. 1:1, 2:1, 3: 1; in the step (1), the molar ratio of the halogenated alkane to the active phenolic hydroxyl groups in the lignin is (1.2-10):1, preferably (1.5-6):1, such as 1.5:1, 2:1, 3:1, 4:1, 5:1, and the molar amount of the halogenated alkane is excessive relative to the active phenolic hydroxyl groups in the lignin.
According to an embodiment of the invention, in the step (2), the mass ratio of the alkylated lignin to the grafting monomer is 1 (10-200), such as 1:13.7, 1:62.5, 1: 139.7.
According to an embodiment of the present invention, the monomer in the step (2) is selected from at least one of levolactide (L-LA), dextrolactide monomer (D-LA) or caprolactone monomer.
According to the embodiment of the invention, the water removal of the anhydrous toluene in the step (2) is carried out for three times or more at 135 ℃ by azeotropy, so that the water content is less than or equal to 0.4 ppm.
According to an embodiment of the present invention, the catalyst in the step (2) is stannous octoate.
The invention provides a lignin grafted polymer copolymer microsphere, which comprises the lignin grafted polymer.
The invention also provides a preparation method of the lignin graft polymer copolymer microsphere, which comprises the steps of dissolving the lignin graft polymer in a solvent to prepare an oil phase (O phase), and mixing the oil phase (O phase) with a pore-forming agent solution (W phase) to obtain a primary emulsion; and adding the primary emulsion into an emulsifier solution, stirring to obtain a secondary emulsion, washing with distilled water, and freeze-drying to obtain the lignin graft polymer copolymer microspheres.
According to an embodiment of the invention, the solvent is dichloromethane or chloroform.
According to an embodiment of the present invention, the mass-to-volume ratio (g/mL) of the lignin graft polymer to the solvent in the oil phase is 1 (5-40), preferably 1 (10-35), such as 1:16, 1: 32.
According to an embodiment of the invention, the mass ratio of the lignin graft polymer to the pore former is 1 (0-0.5), such as 1: 0.25.
According to an embodiment of the invention, the pore former is ammonium bicarbonate and the pore former solution has a mass volume concentration of 0-0.1g/mL, for example: 0g/mL, 0.05g/mL, 0.1 g/mL; the solvent used by the pore-forming agent solution is deionized water. When the mass volume concentration of the pore-forming agent solution is 0g/mL, the size of the lignin graft polymer copolymer microsphere is 180-220 microns and is 0.05g/mL, the size of the lignin graft polymer copolymer microsphere is 230-270 microns and is 0.1g/mL, the size of the lignin graft polymer copolymer microsphere is 260-300 microns; the addition of the pore-forming agent enables the microspheres to have a porous structure, and the content of pores is along with NH4HCO3The content increases.
According to an embodiment of the invention, the volume ratio of the oil phase to the pore former solution is (2-5) to 1, e.g., 3.2: 1; the volume ratio of the oil phase to the emulsifier is 1 (20-50), preferably 1 (30-40), such as 1:37.5
According to an embodiment of the present invention, the emulsifier is polyvinyl alcohol (PVA), and the solvent used for the emulsifier solution is deionized water;
the mass volume concentration of the emulsifier solution is 0-0.01g/mL, such as 0.001g/mL, 0.002 g/mL, 0.005 g/mL;
according to the invention, the mass volume concentration of the lignin graft polymer and the solvent is 0.05-0.1g/mL, preferably 0.0625 g/mL.
In the invention, the lignin graft polymer graft chain segment R2The number average molecular weight of (A) is in the range of 1000 to 3000.
The invention also provides a microsphere porous scaffold material which comprises the lignin grafted polymer copolymer microsphere.
The invention also provides the use of lignin-grafted polymers or polymeric microspheres, which may be used in tissue engineering, which may or may not contain a drug for use in therapy.
Advantageous effects
Compared with the traditional preparation method, the alkylation method can completely react without using a phase transfer agent, and avoids the influence on the optical activity of the polymer, the crystallization and the crystal morphology of the polymer and the performance of the material caused by the introduction of a catalyst in the synthesis process of the polyesters such as LA, CL and the like. The lignin grafted random copolymer obtained by combining polylactic acid and caprolactone improves the flexibility of the lignin-based polyester.
The porous microsphere scaffold prepared by the method can realize the synchronous formation of microspheres and a porous structure, the preparation method is simple and feasible, the raw materials are easy to obtain, the cost is low, the size and the pore diameter of the microspheres can be conveniently controlled by adjusting the freezing time, the freezing temperature, the concentration of a solution and the constant temperature, the porosity is high, the connectivity of pores is good, the pore diameter of surface pores is more uniform, the mechanical strength is excellent, the biocompatibility is good, the scaffold is degradable, has antioxidant activity, is expected to be widely applied to tissue scaffold materials, and has good clinical application prospect.
Drawings
FIG. 1 is a synthetic scheme of alkylated lignin graft polymers prepared in examples 1, 2.
FIG. 2 nuclear magnetism of alkylated lignin prepared in example 1a1H NMR spectrum.
FIG. 3 shows nuclear magnetism of alkylated lignin grafted polylactic acid prepared in a of example 11H NMR spectrum.
FIG. 4 is a GPC chart of alkylated lignin grafted polylactic acid prepared according to the method of example 1 under different charge ratios of alkylated lignin and D-LA.
FIG. 5 is a scanning electron microscope image of the alkylated lignin grafted polylactic acid copolymer microspheres prepared in example 4.
FIG. 6 is an SEM image of the morphology of alkylated lignin-grafted polylactic acid copolymer microspheres according to the method of example 4 at different pore former mass-volume concentrations in the first emulsifier. a is1,b1,c1The shape of the microsphere is larger under a larger visual field; a is2,b2,c2The morphology of a single microsphere; a is3,b3,c3Is an enlarged microsphere surface morphology, wherein a1,a2,a3NH of (2)4HCO3The mass volume concentration is 0 g/mL; b1,b2,b3NH of (2)4HCO3The mass volume concentration is 0.05 g/mL; c. C1,c2,c3NH of (2)4HCO3The mass volume concentration is 0.1 g/mL.
FIG. 7 is an SEM image of the morphology of alkylated lignin grafted polylactic acid copolymer microspheres prepared according to the method of example 4 under the condition of different mass-to-volume ratios of the alkylated lignin grafted polymer to the solvent. a is1,b1The shape of the microsphere is larger under a larger visual field; a is2,b2The morphology of a single microsphere; a is3,b3The surface appearance of the microsphere is enlarged. Wherein a is1,a2,a3The mass volume ratio of the alkylated lignin graft polymer to the solvent is 0.0625 g/mL; b1,b2,b3The mass-volume ratio of the alkylated lignin graft polymer to the solvent is 0.0313 g/mL.
FIG. 8 is a scanning electron microscope image of the alkylated lignin-grafted polylactic acid-polycaprolactone random copolymer microspheres prepared in example 6.
Definition and description of terms
Unless defined otherwise, all technical and scientific terms herein have the same meaning as commonly understood by one of ordinary skill in the art to which the claimed subject matter belongs.
"alkane" used herein alone or as suffix or prefix, is intended to preferably denote a straight or branched chain saturated aliphatic alkane having the indicated number of carbon atoms. Examples of alkanes include, but are not limited to, n-pentane, n-hexane, n-heptane, n-octane, n-nonane, n-decane, n-undecane, n-dodecane, n-tridecane, n-tetradecane, n-pentadecane.
The term "haloalkane" denotes an alkane in which one, two or more hydrogens are replaced by fluorine, chlorine, bromine or iodine, and examples of haloalkanes include, but are not limited to, fluoro-n-pentane, bromo-n-pentane, chloro-n-pentane, iodo-n-pentane, bromo-n-hexane, bromo-n-heptane, bromo-n-octane, bromo-n-nonane, bromo-n-decane, bromo-undecane, bromo-dodecane, iodo-dodecane, bromo-tridecane, bromo-tetradecane, bromo-pentadecane.
The term "inert gas" as used herein, unless otherwise specified, includes gases inert to the reaction, such as nitrogen and noble gases, such as argon.
Detailed Description
The technical solution of the present invention will be further described in detail with reference to specific embodiments. It is to be understood that the following examples are only illustrative and explanatory of the present invention and should not be construed as limiting the scope of the present invention. All the technologies realized based on the above-mentioned contents of the present invention are covered in the protection scope of the present invention.
Unless otherwise indicated, the raw materials and reagents used in the following examples are all commercially available products or can be prepared by known methods.
The units of mass-volume concentrations in the following examples are all g/mL.
Example 1: preparation of alkylated lignin grafted polylactic acid
a, (1) lignin purification: preparing 150mL of 50% alkali lignin solution by using deionized water, preparing 1mol/L NaOH solution to adjust the pH value of the solution to 12, and centrifuging for 15min at 8000r/min by using a centrifuge; carrying out suction filtration on the supernatant to remove insoluble impurities such as suspended cellulose, hemicellulose and the like to obtain a reddish brown transparent solution; slowly dropwise adding 1mol/L hydrochloric acid into the obtained reddish brown transparent solution, adjusting the pH value to 2 to precipitate lignin, and centrifuging for 15min at 8000r/min by using a centrifuge; removing supernatant, washing precipitate with hydrochloric acid solution with pH of 2, freezing with liquid nitrogen for 5min, drying in freeze dryer until no water is apparent, and drying in vacuum oven at 40 deg.C for two days to obtain purified lignin.
(2) Alkylation reaction: and (3) placing the purified lignin in a vacuum oven, drying at 105 ℃ for more than 24 hours, and measuring the total hydroxyl content of 7.298mmol/g and the active phenolic hydroxyl content of 2.673mmol/g in the lignin. The mixture was added to a 250mL beaker using ultrapure water and isopropanol at a volume ratio of 4:1 to prepare an isopropanol solution150mL of solution, 15g of monobromododecane was dissolved in 60mL of isopropanol solution, the mass ratio of monobromododecane to lignin was 1:1, and the molar ratio of monobromododecane to the active phenolic hydroxyl group content of lignin was about 1.5:1, into a 250mL round bottom flask, followed by 15g lignin and 9g K2CO3Stirring and refluxing for 60h at 130 ℃ in an oil bath. After the reaction is finished, cooling to room temperature, centrifuging the product at 8000r/min for 15min, taking out the precipitate, freezing the precipitate for 5min by using liquid nitrogen, putting the precipitate into a freeze dryer, and drying until no obvious water exists; after complete drying, the product is washed with n-hexane for a plurality of times and centrifuged to remove unreacted monobromododecane; finally, the obtained product is placed in a vacuum drying oven at 50 ℃ overnight to obtain the alkylated lignin.
(3) Polymerization reaction: placing the alkylated lignin in a vacuum drying oven for drying at 80 ℃ overnight; placing a Schlenk reaction tube filled with magnetons, a dehydrator, a 250mL round-bottom flask and a needle head glass needle tube in a 120 ℃ oven for 2 hours, and drying for later use; and (4) building a dewatering device, opening a heating sleeve switch, and steaming the methylbenzene to dewater for more than 2 hours until the methylbenzene is discolored.
Taking out the alkylated lignin from the vacuum drying oven, adding 0.365g of the alkylated lignin into a dried 250mL round-bottom flask, putting up a dehydrator, connecting a condenser pipe and a drying ball, and putting the 250mL round-bottom flask in the device into an oil bath; opening the double-row pipe, connecting the baked needle tube with a needle, performing hot pumping three times by using the double-row pipe, performing last pumping to leave part of argon, sucking 60mL of anhydrous toluene from a toluene dewatering device, removing bubbles, adding the anhydrous toluene into a 250mL round-bottom flask containing alkylated lignin, and performing azeotropic dewatering of toluene in 135 ℃ oil bath; after evaporating half of toluene, pumping out the needle tube again, taking anhydrous toluene, adding the anhydrous toluene into the round-bottom flask, and repeating the operation for 3 times; and finally carrying out azeotropic dehydration, and evaporating anhydrous toluene to obtain the residual 20-25 mL.
Pumping and discharging the dried Schlenk reaction tube for three times while the tube is hot, weighing 5g D-LA monomer under the protection of argon, and adding the monomer into the reaction tube, wherein the mass ratio of the alkylated lignin to the D-LA is 1: 13.7; next, 100. mu.L of Sn (Oct) was added under an argon atmosphere2Toluene solution (0.245 g/mL); finally, the needle cylinder is drained for three times, and the alkylated wood after azeotropy in the round-bottom flask is takenPlacing the toluene solution in a reaction tube under the protection of argon; finally, the reaction tube is sealed and reacted for more than 48 hours in an oil bath at 110 ℃.
After the reaction is finished, cooling the reaction tube at room temperature, adding 25mL of chloroform, dissolving the product, centrifuging for 15min at 8000r/min by using a centrifuge, and removing unreacted alkylated lignin; then, precipitating and separating out the product by using 200mL of methanol, putting the product into a centrifuge 8000r/min for centrifugation for 15min, repeatedly washing the product for three times, and removing unreacted monomers; finally, the product was collected and dried in a vacuum oven at 40 ℃ (66% yield) to obtain alkylated lignin grafted polylactic acid with weight average molecular weight Mw＝8.8kg·mol-1，MnIs the number average molecular weight M of the polymern＝5.6kg·mol-1Polymer dispersity index PDI of 1.57(PDI of M)w/Mn) The number average molecular weight of the grafted polylactic acid segment is 1.33 kg/mol-1。
b. Basically, the method a in the embodiment 1 is different in that: the amount of the alkylated lignin in the step (3) was 0.08g, and the obtained alkylated lignin-grafted polylactic acid (yield 91%) had a weight-average molecular weight Mw＝17.5 kg·mol-1，MnIs the number average molecular weight M of the polymerw＝15.0kg·mol-1Polymer dispersity index PDI of 1.17(PDI of M)w/Mn) The number average molecular weight of the grafted polylactic acid segment is 2.00kg & mol-1
c. Basically, the method a in the embodiment 1 is different in that: the amount of the alkylated lignin in the step (3) was 0.036g, and the obtained alkylated lignin-grafted polylactic acid (yield 98%) had a weight-average molecular weight Mw＝24.7 kg·mol-1，MnIs the number average molecular weight M of the polymerw＝18.5kg·mol-1Polymer dispersity index PDI ═ 1.33(PDI ═ M)w/Mn) The number average molecular weight of the grafted polylactic acid segment is 2.27 kg/mol-1。
Example 2: preparation of alkylated lignin grafted polycaprolactone
(1) And (3) lignin purification: preparing 150mL of 50% alkali lignin solution by using deionized water, preparing 1mol/L NaOH solution to adjust the pH value of the solution to 12, and centrifuging for 15min at 8000r/min by using a centrifuge; carrying out suction filtration on the supernatant to remove insoluble impurities such as suspended cellulose, hemicellulose and the like to obtain a reddish brown transparent solution; slowly dropwise adding 1mol/L hydrochloric acid into the obtained reddish brown transparent solution, adjusting the pH value to 2 to precipitate lignin, and centrifuging for 15min at 8000r/min by using a centrifuge; removing supernatant, washing precipitate with hydrochloric acid solution with pH of 2, freezing with liquid nitrogen for 5min, drying in freeze dryer until no water is apparent, and drying in vacuum oven at 40 deg.C for two days to obtain purified lignin.
(2) Alkylation reaction: and (3) placing the purified lignin in a vacuum oven, drying at 105 ℃ for more than 24 hours, and measuring the total hydroxyl content of 7.298mmol/g and the active phenolic hydroxyl content of 2.673mmol/g in the lignin. Adding ultrapure water and isopropanol into a 250mL beaker in a ratio of 4:1 to prepare 150mL of isopropanol solution, dissolving 15g of monobromododecane in 60mL of isopropanol solution, wherein the mass ratio of the monobromododecane to the lignin is 1:1, and the molar ratio of the monobromododecane to the active phenolic hydroxyl content in the lignin is about 1.5:1, into a 250mL round bottom flask, followed by 15g lignin and 9g K2CO3Stirring and refluxing for 60h at 130 ℃ in an oil bath. After the reaction is finished, cooling to room temperature, centrifuging the product at 8000r/min for 15min, taking out the precipitate, freezing the precipitate for 5min by using liquid nitrogen, putting the precipitate into a freeze dryer, and drying until no obvious water exists; after complete drying, the product is washed with n-hexane for a plurality of times and centrifuged to remove unreacted monobromododecane; finally, the obtained product is placed in a vacuum drying oven at 50 ℃ overnight to obtain the alkylated lignin.
(3) Polymerization reaction: placing the alkylated lignin in a vacuum drying oven for drying at 80 ℃ overnight; placing a Schlenk reaction tube filled with magnetons, a dehydrator, a 250mL round-bottom flask and a needle head glass needle tube in a 120 ℃ oven for 2 hours, and drying for later use; and (4) building a dewatering device, opening a heating sleeve switch, and steaming the methylbenzene to dewater for more than 2 hours until the methylbenzene is discolored.
Taking out the alkylated lignin from the vacuum drying oven, adding 0.365g of the alkylated lignin into a dried 250mL round-bottom flask, putting up a dehydrator, connecting a condenser pipe and a drying ball, and putting the 250mL round-bottom flask in the device into an oil bath; opening the double-row pipe, connecting the baked needle tube with a needle, performing hot pumping three times by using the double-row pipe, performing last pumping to leave part of argon, sucking 60mL of anhydrous toluene from a toluene dewatering device, removing bubbles, adding the anhydrous toluene into a 250mL round-bottom flask containing alkylated lignin, and performing azeotropic dewatering of toluene in 135 ℃ oil bath; after evaporating half of toluene, pumping out the needle tube again, taking anhydrous toluene, adding the anhydrous toluene into the round-bottom flask, and repeating the operation for 3 times; and finally carrying out azeotropic dehydration, and evaporating anhydrous toluene to obtain the residual 20-25 mL.
The dried Schlenk reaction tube is pumped and discharged for three times while being hot, and 5g of caprolactone monomers are weighed and added into the reaction tube under the protection of argon; next, 100. mu.L of Sn (Oct) was added under an argon atmosphere2Toluene solution (0.245 g/mL); finally, the needle cylinder is drained for three times, the alkylated lignin toluene solution after azeotropy in the round-bottom flask is taken and placed in a reaction tube under the protection of argon; finally, the reaction tube is sealed and reacted for more than 48 hours in an oil bath at 110 ℃.
After the reaction is finished, cooling the reaction tube at room temperature, adding 25mL of chloroform, dissolving the product, centrifuging for 15min at 8000r/min by using a centrifuge, and removing unreacted alkylated lignin; then, precipitating and separating out the product by using 200mL of methanol, putting the product into a centrifuge 8000r/min for centrifugation for 15min, repeatedly washing the product for three times, and removing unreacted monomers; finally, the product was collected and dried in a vacuum oven at 40 deg.C (68% yield) to yield the alkylated lignin-grafted polycaprolactone.
Example 3: preparation of alkylated lignin grafted polylactic acid-caprolactone random copolymer
(1) And (3) lignin purification: preparing 150mL of 50% alkali lignin solution by using deionized water, preparing 1mol/L NaOH solution to adjust the pH value of the solution to 12, and centrifuging for 15min at 8000r/min by using a centrifuge; carrying out suction filtration on the supernatant to remove insoluble impurities such as suspended cellulose, hemicellulose and the like to obtain a reddish brown transparent solution; slowly dropwise adding 1mol/L hydrochloric acid into the obtained reddish brown transparent solution, adjusting the pH value to 2 to precipitate lignin, and centrifuging for 15min at 8000r/min by using a centrifuge; removing supernatant, washing precipitate with hydrochloric acid solution with pH of 2, freezing with liquid nitrogen for 5min, drying in freeze dryer until no water is apparent, and drying in vacuum oven at 40 deg.C for two days to obtain purified lignin.
(2) Alkylation reaction: and (3) placing the purified lignin in a vacuum oven, drying at 105 ℃ for more than 24 hours, and measuring the total hydroxyl content of 7.298mmol/g and the active phenolic hydroxyl content of 2.673mmol/g in the lignin. Adding ultrapure water and isopropanol into a 250mL beaker in a ratio of 4:1 to prepare 150mL of isopropanol solution, dissolving 15g of monobromododecane in 60mL of isopropanol solution, wherein the mass ratio of the monobromododecane to the lignin is 1:1, and the molar ratio of the monobromododecane to the active phenolic hydroxyl content in the lignin is about 1.5:1, into a 250mL round bottom flask, followed by 15g lignin and 9g K2CO3Stirring and refluxing for 60h at 130 ℃ in an oil bath. After the reaction is finished, cooling to room temperature, centrifuging the product at 8000r/min for 15min, taking out the precipitate, freezing the precipitate for 5min by using liquid nitrogen, putting the precipitate into a freeze dryer, and drying until no obvious water exists; after complete drying, the product is washed with n-hexane for a plurality of times and centrifuged to remove unreacted monobromododecane; finally, the obtained product is placed in a vacuum drying oven at 50 ℃ overnight to obtain the alkylated lignin.
(3) Polymerization reaction: placing the alkylated lignin in a vacuum drying oven for drying at 80 ℃ overnight; placing a Schlenk reaction tube filled with magnetons, a dehydrator, a 250mL round-bottom flask and a needle head glass needle tube in a 120 ℃ oven for 2 hours, and drying for later use; and (4) building a dewatering device, opening a heating sleeve switch, and steaming the methylbenzene to dewater for more than 2 hours until the methylbenzene is discolored.
Taking out the alkylated lignin from the vacuum drying oven, adding 0.365g of the alkylated lignin into a dried 250mL round-bottom flask, putting up a dehydrator, connecting a condenser pipe and a drying ball, and putting the 250mL round-bottom flask in the device into an oil bath; opening the double-row pipe, connecting the baked needle tube with a needle, performing hot pumping three times by using the double-row pipe, performing last pumping to leave part of argon, sucking 60mL of anhydrous toluene from a toluene dewatering device, removing bubbles, adding the anhydrous toluene into a 250mL round-bottom flask containing alkylated lignin, and performing azeotropic dewatering of toluene in 135 ℃ oil bath; after evaporating half of toluene, pumping out the needle tube again, taking anhydrous toluene, adding the anhydrous toluene into the round-bottom flask, and repeating the operation for 3 times; and finally carrying out azeotropic dehydration, and evaporating anhydrous toluene to obtain the residual 20-25 mL.
Pumping and discharging the dried Schlenk reaction tube for three times while the tube is hot, and weighing 5g of CL monomer and 5g D-LA under the protection of argon gas and adding the CL monomer and the 5g D-LA into the reaction tube; then, under the protection of argon, 100. mu.L of Sn (Oct)2 toluene solution (0.245g/mL) was added; finally, the needle cylinder is drained for three times, the alkylated lignin toluene solution after azeotropy in the round-bottom flask is taken and placed in a reaction tube under the protection of argon; finally, the reaction tube is sealed and reacted for more than 48 hours in an oil bath at 110 ℃.
After the reaction is finished, cooling the reaction tube at room temperature, adding 25mL of chloroform, dissolving the product, centrifuging for 15min at 8000r/min by using a centrifuge, and removing unreacted alkylated lignin; then, precipitating and separating out the product by using 200mL of methanol, putting the product into a centrifuge 8000r/min for centrifugation for 15min, repeatedly washing the product for three times, and removing unreacted monomers; finally, the product was collected and dried in a vacuum oven at 40 ℃ (55% yield) to obtain an alkylated lignin grafted polylactic acid-caprolactone random copolymer with a weight average molecular weight Mw of 13.4kg · mol-1Number average molecular weight Mn of 10.9 kg/mol-1Polymer dispersibility index PDI ═ 1.23(PDI ═ Mw/Mn), the number average molecular weight of the grafted polylactic acid segment: 0.76 kg. mol-1Number average molecular weight of the grafted polycaprolactone segment: 0.91 kg mol-1。
Example 4: preparation of alkylated lignin grafted polylactic acid copolymer microspheres
0.25g of the alkylated lignin-grafted polylactic acid polymer prepared in example 1 was weighed into a clean glass vial, 4mL of chloroform was added as a solvent, and dissolved by magnetic stirring to obtain an oil phase. And taking a clean bottle, and preparing 1.25mL of ammonium bicarbonate aqueous solution with the mass volume concentration of 0.05g/mL, wherein the solvent of the ammonium bicarbonate aqueous solution is deionized water, and the ammonium bicarbonate solution is used as an internal water phase. Mixing the internal water phase and the oil phase together under the condition of ice bath, homogenizing for three minutes at the maximum rotation speed of a homogenizer to obtain a primary emulsion, pouring the homogenized primary emulsion into 150mL of PVA deionized water solution with the mass volume concentration of 0.001g/mL, and stirring for four hours to obtain a secondary emulsion. And in the process of secondary emulsification, obtaining porous microspheres, repeatedly washing the obtained microspheres with distilled water, and freeze-drying to obtain the alkylated lignin grafted polylactic acid copolymer microspheres.
Example 5: preparation of alkylated lignin grafted polycaprolactone copolymer microspheres
0.25g of the alkylated lignin-grafted polycaprolactone polymer prepared in example 2 was weighed into a clean glass vial, 4mL of chloroform was added as solvent and dissolved by magnetic stirring to give an oil phase. And taking a clean bottle, and preparing 1.25mL of ammonium bicarbonate solution with the mass volume concentration of 0.05g/mL, wherein the solvent is deionized water, and the ammonium bicarbonate solution is used as an internal water phase. Mixing the internal water phase and the oil phase together under the condition of ice bath, homogenizing for three minutes at the maximum rotation speed of a homogenizer to obtain a primary emulsion, pouring the homogenized primary emulsion into 150mL of PVA deionized water solution with the mass volume concentration of 0.001g/mL, and stirring for four hours to obtain a secondary emulsion. And in the process of secondary emulsification, obtaining porous microspheres, repeatedly washing the obtained microspheres with distilled water, and freeze-drying to obtain the alkylated lignin grafted polycaprolactone copolymer microspheres.
Example 6: preparation of alkylated lignin grafted polylactic acid-caprolactone random copolymer microspheres
0.25g of the alkylated lignin graft polylactic acid-caprolactone random copolymer prepared in example 3 was weighed into a clean glass vial, 4mL of chloroform was added as a solvent, and dissolved by magnetic stirring to obtain an oil phase. And taking a clean bottle, and preparing 1.25mL of ammonium bicarbonate solution with the mass volume concentration of 0.05g/mL, wherein the solvent is deionized water, and the ammonium bicarbonate solution is used as an internal water phase. Mixing the internal water phase and the oil phase together under the condition of ice bath, homogenizing for three minutes at the maximum rotation speed of a homogenizer to obtain a primary emulsion, pouring the homogenized primary emulsion into 150mL of PVA deionized water solution with the mass volume concentration of 0.001g/mL, and stirring for four hours to obtain a secondary emulsion. And in the process of secondary emulsification, obtaining porous microspheres, repeatedly washing the obtained microspheres with distilled water, and freeze-drying to obtain the alkylated lignin grafted polylactic acid-caprolactone random copolymer microspheres.
The embodiments of the present invention have been described above. However, the present invention is not limited to the above embodiment. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911311181.9A CN112979928A (en) | 2019-12-18 | 2019-12-18 | Preparation method of lignin grafted polymer microspheres |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911311181.9A CN112979928A (en) | 2019-12-18 | 2019-12-18 | Preparation method of lignin grafted polymer microspheres |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112979928A true CN112979928A (en) | 2021-06-18 |
Family
ID=76343974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911311181.9A Pending CN112979928A (en) | 2019-12-18 | 2019-12-18 | Preparation method of lignin grafted polymer microspheres |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112979928A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114349945A (en) * | 2022-01-14 | 2022-04-15 | 南京先进生物材料与过程装备研究院有限公司 | Modified lignin polyol and preparation method thereof |
| CN114672031A (en) * | 2022-04-15 | 2022-06-28 | 苏州市焕彤科技有限公司 | PH response polymer nano-drug and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101249077A (en) * | 2008-04-14 | 2008-08-27 | 西南交通大学 | A kind of preparation method and application of degradable polymer porous microsphere |
-
2019
- 2019-12-18 CN CN201911311181.9A patent/CN112979928A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101249077A (en) * | 2008-04-14 | 2008-08-27 | 西南交通大学 | A kind of preparation method and application of degradable polymer porous microsphere |
Non-Patent Citations (2)
| Title |
|---|
| DAN KAI等: "Engineering Poly(lactide)-Lignin Nanofibers with Antioxidant Activity for Biomedical Application", 《ACS SUSTAINABLE CHEM. ENG.》 * |
| WEI REN等: "Dodecylated lignin-g-PLA for effective toughening of PLA", 《GREEN CHEM.》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114349945A (en) * | 2022-01-14 | 2022-04-15 | 南京先进生物材料与过程装备研究院有限公司 | Modified lignin polyol and preparation method thereof |
| CN114349945B (en) * | 2022-01-14 | 2023-08-15 | 南京先进生物材料与过程装备研究院有限公司 | Modified lignin polyol and preparation method thereof |
| CN114672031A (en) * | 2022-04-15 | 2022-06-28 | 苏州市焕彤科技有限公司 | PH response polymer nano-drug and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ma et al. | Synthesis and characterization of injectable self-healing hydrogels based on oxidized alginate-hybrid-hydroxyapatite nanoparticles and carboxymethyl chitosan | |
| JP2986509B2 (en) | Modified polyester resin composition, method for producing the same, and use thereof | |
| Nazeer et al. | Electrospun polycaprolactone/silk fibroin nanofibrous bioactive scaffolds for tissue engineering applications | |
| Huang et al. | Functional polyhedral oligomeric silsesquioxane reinforced poly (lactic acid) nanocomposites for biomedical applications | |
| Hu et al. | Fluorescence imaging enabled poly (lactide-co-glycolide) | |
| Pourbashir et al. | Preparation and characterization of semi-IPNs of polycaprolactone/poly (acrylic acid)/cellulosic nanowhisker as artificial articular cartilage | |
| CN102952385A (en) | Modified halloysite nanotube / biodegradable polyester composite material and preparation method thereof | |
| JPS6139329B2 (en) | ||
| US20030215483A1 (en) | Medical materials and porous scaffolds for tissue engineering made from the biodegradable glycolide/epsilon-caprolactone copolymer | |
| CN110938200B (en) | A kind of preparation method of side chain containing lutidine amine polyester | |
| CN112979928A (en) | Preparation method of lignin grafted polymer microspheres | |
| CN106700098A (en) | Preparation method of biodegradable supermolecule polylactic acid microspheres | |
| CN101054441A (en) | Terpolymer for controllable degradation of carbon dioxide/epoxide/lactone and preparation method thereof | |
| KR100288103B1 (en) | Biodegradable aliphatic polyester grafted with polyether and its preparation method | |
| CN103570884B (en) | Preparation method for maleic anhydride-modified polylactic-co-glycolic acid | |
| Yang et al. | Fabrication, hydrolysis and cell cultivation of microspheres from cellulose-graft-poly (L-lactide) copolymers | |
| CN108192033A (en) | A kind of maleic anhydride is directly grafted the preparation method of L- lactide/glycolides/6-caprolactone terpolymer | |
| Kandil et al. | Hydroxyapatite/hyperbranched polyitaconic acid/chitosan composite scaffold for bone tissue engineering | |
| CN101633730B (en) | Polyphosphate ester-polylactic acid triblock copolymer and application thereof | |
| Xiao et al. | Synthesis and characterization of cellulose-graft-poly (L-lactide) via ring-opening polymerization. | |
| CN116554449A (en) | Preparation method of segmented structure controllable absorbable block copolymer microsphere | |
| CN101704906A (en) | Method for one-step synthesis of chitosan graft polycaprolactone cationic copolymer and application thereof | |
| CN101445607A (en) | Copolymer of fibroin and poly D,L-lactic acid, preparation method and application thereof | |
| JP2606260B2 (en) | Block copolymer | |
| CN107737119A (en) | A kind of PCL PLGA sustained release preparations and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210618 |